Professor Peter Hindmarsh, described as a “leading expert” in insulin by lead prosecutor Nick Johnson KC, was suspended from seeing patients by University College London Hospitals NHS Foundation Trust (UCLH) in March 2023. @havovan/X
Medicine

Lucy Letby Trial: Insulin Expert Peter Hindmarsh Faced Child Safety Concerns – Why Was the Jury Not Told About His Clinical Ban?

Investigations reveal Prof. Peter Hindmarsh was suspended from clinical practice during the trial, raising new disclosure questions and scientific scrutiny ahead of the CCRC review

Author : Akanksha

A paediatric endocrinology expert whose evidence helped convict former neonatal nurse Lucy Letby has been suspended from seeing patients in connection with safety concerns for children. 

Professor Peter Hindmarsh, described as a “leading expert” in insulin by lead prosecutor Nick Johnson KC, was suspended from seeing patients by University College London Hospitals NHS Foundation Trust (UCLH) in March 2023. This was just five months before Letby’s first trial finished, and neither the jury nor Letby’s defence were made aware of the suspension. This was an employer-imposed restriction by UCLH, not a suspension of Hindmarsh’s registration by the General Medical Council (GMC).

Letby, 36, has received 15 life sentences for murdering 7 babies and attempting to murder 7 babies at the Countess of Chester Hospital between June 2015 and June 2016. However, she has always claimed her innocence. Letby’s solicitor, Mark McDonald, has made an application to the Criminal Cases Review Commission (CCRC) to refer the case back to the Court of Appeal. 

Why Was Lucy Letby Trial Expert Prof. Peter Hindmarsh Barred From Treating Patients?

Internal documentation obtained by The Guardian shows that UCLH informed the General Medical Council (GMC) that Hindmarsh was suspended from ‘all patient-related work’ on March 15, 2023. This was just under 3 weeks after Hindmarsh gave his second and final evidence in Manchester Crown Court on February 24, 2023. 

A letter was sent to the GMC by UCLH medical director Dr. Tim Hodgson, who said that Hindmarsh had breached a supervision order placed in January 2023. He had provided independent medical advice for 3 children at the hospital, 2 of whom had related conditions with insulin and diabetes. In the letter, Hodgson told the GMC that he did not believe UCLH could accept the level of risk Professor Hindmarsh appears to pose to children and young people, even with close clinical supervision.1

Unsafe Home Insulin Advice and Diabetic Ketoacidosis (DKA) Risk

Hindmarsh gave advice to parents of two children to stop administering insulin at home. As a result, one child developed Diabetic Ketoacidosis (DKA), a life-threatening condition caused by extreme insulin deficiency. However, Hodgson specifically stated that it was unclear whether the DKA episode coincided with Hindmarsh’s alleged advice.

Over Focus on Rare Causes of Hypoglycemia and Diabetes

Colleagues have raised concerns that Hindmarsh focused too heavily on rarer causes of hypoglycemia and diabetes, and failed to investigate more common causes and adequately manage hyperglycemia. 

Previous Great Ormond Street Hospital Removal and GMC Investigation

Four months before Hindmarsh first gave evidence in November 2022, Great Ormond Street Hospital (GOSH) terminated his honorary consultant contract in July 2022. GOSH raised “multiple and wide-ranging concerns” with the GMC relating to patient diagnosis and potential harm. In court, when asked if he was an honorary consultant at GOSH, Hindmarsh responded, “Yes. At that stage, yes,” and did not clarify that he had been removed. 

However, in April 2023, following an application for suspension from the GMC, a Medical Practitioner Tribunal ruled that suspension was excessive. The tribunal instead tightened the existing supervision requirements, ordering that Hindmarsh be directly supervised when treating patients. It also allowed him to continue non-clinical work, including acting as an expert witness. However, this decision had no practical effect on his clinical practice at UCLH, as the hospital had already barred him from treating patients. The GMC investigation was concluded in November 2024 without a final decision due to Hindmarsh achieving voluntary erasure from the medical register.

Also Read: Does Taking Insulin Make Life Insurance More Expensive?

Lucy Letby Trial: Expert Witness Disclosure Questions and the CCRC Review

According to the Criminal Procedure Rules in England and Wales, introduced in 2014 to prevent miscarriages of justice, if an expert witness is subject to regulatory proceedings, or if there is information that could cast doubt on their credibility, it must be disclosed to the instructing party.

Tim Green KC, an expert in disclosure, told The Guardian that this disclosure obligation applies throughout the proceedings, including appeals. Arguably, it still applies now, with regard to current considerations by the CCRC.  

Although Cheshire Constabulary were made aware of the initial GMC investigation in December 2022, and the Crown Prosecution Service (CPS) informed Letby’s barrister, at the time, Ben Myers KC, in February 2023, the defence were never made aware of Hindmarsh being suspended from clinical practice in March 2023, or the ruling of the tribunal in April 2023. The CPS told The Guardian that all disclosure requirements have been met, as they were never made aware of the later suspension.

Mark McDonald told The Sun that Hindmarsh’s evidence was crucial, forming the bedrock of the prosecution case: “It influenced how the jury viewed Lucy Letby and how they viewed all other allegations in evidence.” No direct or forensic evidence exists to show that Letby or anyone else injected insulin into IV bags. The Guardian reported that there was no direct or forensic evidence showing that Letby or anyone else had injected insulin into the IV bags.

Questions About Insulin Poisoning Evidence and Immunoassay Reliability in the Lucy Letby Case

In addition to the disclosure concerns, independent scientists and clinicians have raised concerns about the clinical basis of the conviction of insulin poisoning in two babies (Baby F and Baby L). During the trial, exogenous insulin poisoning was concluded from immunoassay test results. However, 7 experts have submitted reports to the CCRC, arguing that immunoassay can give false-positive results due to interference from antibodies. Dr. Hodgson’s report to the GMC in March 2023 highlights that Hindmarsh himself warned a patient’s family that the insulin antibody test was an “unreliable test,” therefore fallible. However, that was not communicated to the jury in the Letby case. 

A paediatric endocrinology expert whose evidence helped convict former neonatal nurse Lucy Letby has been suspended from seeing patients in connection with safety concerns for children.

Dr. Adel Ismail, a leading clinical biochemist, told BBC File on 4 that confirmation tests are crucial. He said that his research had found an error rate of one in 200. This is Ismail's reported estimate and should not be interpreted as a universal error rate for all immunoassay tests. A peer-reviewed observational study by Ismail et al. showed that in 5,310 patients, endogenous interfering antibodies were causing misleading results in immunoassays and could lead to serious misinterpretations in patient diagnosis if not confirmed.1 The study examined these hormone assays; it was not a study of insulin immunoassay results from Baby F or Baby L. Clinical pathology reviews have confirmed that secondary confirmation testing is required to overcome cross-reactivity and heterophilic antibodies in immunoassays.2 In Baby F and Baby L’s cases, no confirmation tests were carried out as both babies quickly recovered. 

Mathematical Modelling of Preterm Infant Insulin Doses 

Prosecutors claimed that only a few drops of insulin were required to cause poisoning in Baby F and Baby L. However, Professor Geoff Chase from the University of Canterbury and chemical engineer Helen Shannon have challenged this claim using mathematical models of preterm infant metabolism. 

Based on over 15 years of research in metabolic models of glycemic control in neonates, showing large variation in insulin sensitivity and clearance in neonates,3 they calculated that significantly more insulin would be required, between 20-80 times more in Baby L’s case, to achieve the blood concentrations seen. No evidence was shown in court that large amounts of insulin were missing from the ward. 

Other Medical Evidence Challenged in the Lucy Letby Case 

Concerns have been raised in relation to other babies. As reported by The Guardian, Dr. Shoo Lee, a neonatologist from Canada, formed an international expert panel consisting of 14 members. They concluded unanimously that Baby C, Baby O, and others had died or fallen ill as a result of natural causes and poor care within the unit, and not deliberate harm. 

Baby C: Contested X-Ray Findings and Natural Causes 

Witnesses for the prosecution claimed that, on an X-ray taken on June 12, air had been deliberately injected into Baby C’s stomach. However, as Letby was not working on this day, neonatologist Dr. Michael Hall told the BBC that the excess air was likely due to respiratory support and a bowel obstruction. Similarly, retired Cambridge professor Colin Morley stated that he was “very confident” that Baby C died due to natural causes. 

Baby O: Perinatal Pathologist Disputes Liver Injury Evidence 

Although the prosecution pathologist compared liver damage in Baby O to that seen in road traffic accidents, a senior perinatal pathologist told BBC File on 4 that she agreed with the initial conclusion of natural causes. She said she has seen similar injuries in natural causes in patients at least 3 times in her career. 

Lady Justice Thirlwall, who led the public inquiry into the Countess of Chester Hospital for 2 years, has refused to investigate claims of miscarriage of justice. Recommendations to improve safety in the NHS were published in September based on the assumption that Letby was guilty. However, the CPS told the BBC that two juries and the Court of Appeal have supported Letby’s conviction on 15 counts. The CCRC is being asked to assess the new expert reports and disclosure concerns submitted by Letby's legal team and decide whether the case should be referred back to the Court of Appeal. The application does not mean that the convictions have been overturned or that a miscarriage of justice has been established.

Also Read: Can GLP-1s Help People Stop Insulin?

References: 

  1. Ismail, A. A., P. L. Walker, J. H. Barth, K. C. Lewandowski, R. Jones, and W. A. Burr. “Wrong Biochemistry Results: Two Case Reports and Observational Study in 5310 Patients on Potentially Misleading Thyroid-Stimulating Hormone and Gonadotropin Immunoassay Results.” Clinical Chemistry 48, no. 11 (2002): 2023–2029. 

    https://pubmed.ncbi.nlm.nih.gov/12406989/.

  2. Ismail, A. A. “Interference from Endogenous Antibodies in Automated Immunoassays: What Laboratorians Need to Know.” Journal of Clinical Pathology 62, no. 8 (2009): 673–678. 

    https://pubmed.ncbi.nlm.nih.gov/19638536/.

  3. Chase, J. G., A. J. Le Compte, F. Suhaimi, G. M. Shaw, A. Lynn, J. Lin, C. G. Pretty, N. Razak, J. D. Parente, C. E. Hann, J. C. Preiser, and T. Desaive. “Tight Glycemic Control in Critical Care—The Leading Role of Insulin Sensitivity and Patient Variability: A Review and Model-Based Analysis.” Computer Methods and Programs in Biomedicine 102, no. 2 (2011): 156–171. 

    https://pubmed.ncbi.nlm.nih.gov/21145614/. 

(Rh/APC/MSM)

Best Legal Services for Nursing Home Abuse Cases in Chicago

Best Personal Injury Lawyers for Medical Malpractice

International Men’s Day 2026: Essential Preventive Health Checkups Every Indian Man Should Prioritize

Rolling Back Decades of Protection: Inside the Controversy Over India’s 2026 Lab Animal Rules

How a DBA in Healthcare Management Changes the Way You Lead in Modern Care